FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| IPO Open | June 12, 2019 |
| IPO Close | June 21, 2019 |
| IPO Price | ₹72 |
| Face Value | ₹10 |
| IPO Size | ₹24.77 Cr |
| Listing At | NSE SME |
| Lot Size | 1600 |
Sep 12, 2023 3:30:00 AM
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in job work manufacturing in pharmaceutical items and traders in chemicals and solvents in India. The Company is ...
Publish by : MintSep 2, 2023 2:55:00 AM
Saroja Pharma Industries India IPO has received a decent response from investors on its second day of bidding, September 1. The participants bought 21.76 lakh shares in the IPO, higher by 2.01 ...
Publish by : moneycontrol.comAug 25, 2023 1:29:00 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Publish by : InvestingSep 8, 2023 5:14:00 PM
Premium Saroja Pharma Industries IPO share allotment will be finalised today (Friday, September 8). Saroja Pharma IPO allotment date: Saroja Pharma Industries IPO share allotment will be finalised ...
Publish by : MintAug 31, 2023 7:27:00 AM
The Initial Public Offering of Saroja Pharma Industries India Limited will open for subscription on Thursday, August 31 and will continue till Tuesday, September 5. The IPO is a fixed price issue ...
Publish by : MSNAug 31, 2023 2:02:00 PM
The initial public offering of Saroja Pharma Industries India was subscribed to 77 percent on August 31, the first day of bidding, receiving bids for 8.35 lakh equity shares against offer size ...
Publish by : moneycontrol.comJul 19, 2023 3:20:00 PM
If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close. If the biotech bull market hasn't reached 11 on the absurdity meter quite yet ...
Publish by : TheStreet.comSep 3, 2021 3:25:00 PM
Several pharma and specialty chemical companies launched their initial public offerings (IPOs), hastened by the disruptions brought about by the pandemic. The frenzy of IPOs shows no sign of ...
Publish by : OutlookindiaMay 12, 2020 7:36:00 PM
LTRN believes it can better stratify patient populations for improved trial results for previously failed Phase 3 trials drug candidates. LTRN believes it can better stratify patient populations ...
Publish by : TheStreet.comMay 8, 2023 10:04:00 AM
The IPO was issued at Rs 1,080 with a price range of Rs 1,026-1,080 per share, and a lot of Mankind Pharma comprised of 13 shares. The IPO received an overwhelming response from investors ...
Publish by : MSNFeb 11, 2023 7:58:00 PM
The scale of the IPO � which is the largest in the US this year across all industrial sectors � reflects Royalty Pharma�s position as the largest player in the niche area of pharmaceutical ...
Publish by : pharmaphorumSep 8, 2023 10:00:00 PM
Sudarshan Pharma Industries Ltd share price was up by 1.02% from the previous closing price of ?85.04. Who are peers of Sudarshan Pharma Industries Ltd? The peers of Sudarshan Pharma Industries ...
Publish by : Business TodaySudarshan Pharma Industries Limited is entering in the capital market with an IPO of 3,440,000 Equity Shares of Rs 10 aggregating up to Rs 24.77 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The issue opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME.
The issue of Sudarshan Pharma Industries Limited opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Sudarshan Pharma IPO is proposed to open on June 12, 2019. The IPO application ends on June 21, 2019.
Retail investors can apply in the retail or non-institutional investor category from June 12, 2019 to June 21, 2019. The Sudarshan Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Sudarshan Pharma IPO will open for subscription on June 12, 2019. The public issue will close on June 21, 2019.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
|
|
RHP
